The art of classifying mild, temporary, or situational symptoms as medical diseases has become more prevalent in the healthcare industry in recent years. A large number of people have become familiar with medical labels, whether they are for “borderline” lab results, self-diagnosed concentration problems, or mild hormonal swings.
Although a deeper understanding has aided in the early detection of true illness, it also asks the crucial question: Are we now beginning to medicalize typical human experience?
What Is Driving This Trend?
Several factors contribute:
-
Expanded diagnostic criteria
-
Increased screening and preventive testing
-
Direct-to-consumer health information
-
Social media health trends
-
Defensive medicine practices
Lowering diagnostic standards not only helps with the early identification of high-risk patients but also results in a greater number of people being classed as “patients” without any evident benefit.
Potential Consequences
- Overdiagnosis and overtreatment
- Unnecessary medication exposure
- Increased healthcare costs
- Health anxiety
- Reduced resilience toward normal life stressors
Labelling can offer reliability in most situations. While some may turn out to be dependent on medical systems for conditions that may be treated by themselves.
The Balance We Need
The challenge is not to ignore symptoms, but to differentiate between:
-
Early disease that requires intervention
-
Risk factors that need monitoring
-
Normal biological variation
Not every departure from the “ideal” should be classified as pathology in the context of precision medicine.
How do medical professionals determine the boundary between early detection and overdiagnosis?